|
1
|
Azab AK, Runnels JM, Pitsillides C, Moreau
AS, Azab F, Leleu X, Jia X, Wright R, Ospina B, Carlson AL, et al:
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple
myeloma cells with the bone marrow microenvironment and enhances
their sensitivity to therapy. Blood. 113:4341–4351. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bjorklund CC, Baladandayuthapani V, Lin
HY, Jones RJ, Kuiatse I, Wang H, Yang J, Shah JJ, Thomas SK, Wang
M, et al: Evidence of a role for CD44 and cell adhesion in
mediating resistance to lenalidomide in multiple myeloma:
Therapeutic implications. Leukemia. 28:373–383. 2014. View Article : Google Scholar
|
|
3
|
Shao S, Huang X, Wang Y, He S, Xu X, Zhu
X, Yang X, Ding Z, Yao L, Huang Y, et al: A role for activator of
G-protein signaling 3 (AGS3) in multiple myeloma. Int J Hematol.
99:57–68. 2014. View Article : Google Scholar
|
|
4
|
Krönke J, Udeshi ND, Narla A, Grauman P,
Hurst SN, McConkey M, Svinkina T, Heckl D, Comer E, Li X, et al:
Lenalidomide causes selective degradation of IKZF1 and IKZF3 in
multiple myeloma cells. Science. 343:301–305. 2014. View Article : Google Scholar :
|
|
5
|
Abdi J, Garssen J and Redegeld F:
Toll-like receptors in human multiple myeloma: New insight into
inflammation-related pathogenesis. Curr Mol Med. 14:423–431. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdi J, Mutis T, Garssen J and Redegeld
FA: Toll-like receptor (TLR)-1/2 triggering of multiple myeloma
cells modulates their adhesion to bone marrow stromal cells and
enhances bortezomib-induced apoptosis. PLoS One. 9:e966082014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cho HY and Lee SW: TLR5 activation by
flagellin induces doxorubicin resistance via interleukin-6 (IL-6)
expression in two multiple myeloma cells. Cell Immunol. 289:27–35.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murray ME, Gavile CM, Nair JR, Koorella C,
Carlson LM, Buac D, Utley A, Chesi M, Bergsagel PL, Boise LH, et
al: CD28-mediated pro-survival signaling induces chemotherapeutic
resistance in multiple myeloma. Blood. 123:3770–3779. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pei XY, Dai Y, Felthousen J, Chen S,
Takabatake Y, Zhou L, Youssefian LE, Sanderson MW, Bodie WW, Kramer
LB, et al: Circumvention of Mcl-1-dependent drug resistance by
simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma
cells. PLoS One. 9:e890642014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fei M, Hang Q, Hou S and Ruan C: Cell
adhesion to fibronectin down-regulates the expression of Spy1 and
contributes to drug resistance in multiple myeloma cells. Int J
Hematol. 98:446–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kiziltepe T, Ashley JD, Stefanick JF, Qi
YM, Alves NJ, Handlogten MW, Suckow MA, Navari RM and Bilgicer B:
Rationally engineered nanoparticles target multiple myeloma cells,
overcome cell-adhesion-mediated drug resistance, and show enhanced
efficacy in vivo. Blood Cancer J. 2:e642012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neri P and Bahlis NJ: Targeting of
adhesion molecules as a therapeutic strategy in multiple myeloma.
Curr Cancer Drug Targets. 12:776–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neri P, Ren L, Azab AK, Brentnall M,
Gratton K, Klimowicz AC, Lin C, Duggan P, Tassone P, Mansoor A, et
al: Integrin β7-mediated regulation of multiple myeloma cell
adhesion, migration, and invasion. Blood. 117:6202–6213. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen T, Fei F, Jiang XF, Zhang L, Qu Y,
Huo K and Fei Z: Down-regulation of Homer1b/c attenuates
glutamate-mediated excitotoxicity through endoplasmic reticulum and
mitochondria pathways in rat cortical neurons. Free Radic Biol Med.
52:208–217. 2012. View Article : Google Scholar
|
|
15
|
Yao YX, Jiang Z and Zhao ZQ: Knockdown of
synaptic scaffolding protein Homer 1b/c attenuates secondary
hyperalgesia induced by complete Freund's adjuvant in rats. Anesth
Analg. 113:1501–1508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv MM, Cheng YC, Xiao ZB, Sun MY, Ren PC
and Sun XD: Down-regulation of Homer1b/c attenuates group I
metabotropic glutamate receptors dependent Ca2+
signaling through regulating endoplasmic reticulum Ca2+
release in PC12 cells. Biochem Biophys Res Commun. 450:1568–1574.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakano-Kobayashi A, Tai Y, Nadif Kasri N
and Van Aelst L: The X-linked mental retardation protein OPHN1
interacts with Homer1b/c to control spine endocytic zone
positioning and expression of synaptic potentiation. J Neurosci.
34:8665–8671. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Bartolomeis A, Tomasetti C, Cicale M,
Yuan PX and Manji HK: Chronic treatment with lithium or valproate
modulates the expression of Homer1b/c and its related genes Shank
and Inositol 1,4,5-trisphosphate receptor. Eur
Neuropsychopharmacol. 22:527–535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fei F, Rao W, Zhang L, Chen BG, Li J, Fei
Z and Chen Z: Downregulation of Homer1b/c improves neuronal
survival after traumatic neuronal injury. Neuroscience.
267:187–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng X, Pan ZG, Shao Y, Wu XN, Liu SX, Li
NL and Wang WM: SKF-96365 attenuates toxin-induced neuronal injury
through opposite regulatory effects on Homer1a and Homer1b/c in
cultured rat mesencephalic cells. Neurosci Lett. 543:183–188. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miletic G, Miyabe T, Gebhardt KJ and
Miletic V: Increased levels of Homer1b/c and Shank1a in the
post-synaptic density of spinal dorsal horn neurons are associated
with neuropathic pain in rats. Neurosci Lett. 386:189–193. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Azab F, Vali S, Abraham J, Potter N, Muz
B, de la Puente P, Fiala M, Paasch J, Sultana Z, Tyagi A, et al:
PI3KCA plays a major role in multiple myeloma and its inhibition
with BYL719 decreases proliferation, synergizes with other
therapies and overcomes stroma-induced resistance. Br J Haematol.
165:89–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Emmons MF, Gebhard AW, Nair RR, Baz R,
McLaughlin ML, Cress AE and Hazlehurst LA: Acquisition of
resistance toward HYD1 correlates with a reduction in cleaved α4
integrin expression and a compromised CAM-DR phenotype. Mol Cancer
Ther. 10:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fei M, Hang Q, Hou S, He S and Ruan C:
Adhesion to fibronectin induces p27(Kip1) nuclear accumulation
through down-regulation of Jab1 and contributes to cell
adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells. Mol
Cell Biochem. 386:177–187. 2014. View Article : Google Scholar
|
|
25
|
Noborio-Hatano K, Kikuchi J, Takatoku M,
Shimizu R, Wada T, Ueda M, Nobuyoshi M, Oh I, Sato K, Suzuki T, et
al: Bortezomib overcomes cell-adhesion-mediated drug resistance
through downregulation of VLA-4 expression in multiple myeloma.
Oncogene. 28:231–242. 2009. View Article : Google Scholar
|
|
26
|
Huang X, Wang Y, Nan X, He S, Xu X, Zhu X,
Tang J, Yang X, Yao L, Wang X, et al: The role of the orphan G
protein-coupled receptor 37 (GPR37) in multiple myeloma cells. Leuk
Res. 38:225–235. 2014. View Article : Google Scholar
|
|
27
|
Morelli MB, Offidani M, Alesiani F,
Discepoli G, Liberati S, Olivieri A, Santoni M, Santoni G, Leoni P
and Nabissi M: The effects of cannabidiol and its synergism with
bortezomib in multiple myeloma cell lines. A role for transient
receptor potential vanilloid type-2. Int J Cancer. 134:2534–2546.
2014. View Article : Google Scholar
|
|
28
|
Paulus A, Chitta K, Akhtar S, Personett D,
Miller KC, Thompson KJ, Carr J, Kumar S, Roy V, Ansell SM, et al:
AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic
effects of lenalidomide and dexamethasone in preclinical models of
multiple myeloma and Waldenström macroglobulinaemia. Br J Haematol.
164:352–365. 2014. View Article : Google Scholar
|
|
29
|
Ramírez-Labrada A, López-Royuela N,
Jarauta V, Galán-Malo P, Azaceta G, Palomera L, Pardo J, Anel A,
Marzo I and Naval J: Two death pathways induced by sorafenib in
myeloma cells: Puma-mediated apoptosis and necroptosis. Clin Transl
Oncol. 17:121–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sook SH, Lee HJ, Kim JH, Sohn EJ, Jung JH,
Kim B, Kim JH, Jeong SJ and Kim SH: Reactive oxygen
species-mediated activation of AMP-activated protein kinase and
c-Jun N-terminal kinase plays a critical role in
beta-sitosterol-induced apoptosis in multiple myeloma U266 cells.
Phytother Res. 28:387–394. 2014. View
Article : Google Scholar
|
|
31
|
Stephens M, McKenzie H and Jordens CF: The
work of living with a rare cancer: Multiple myeloma. J Adv Nurs.
70:2800–2809. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo S, Zhi Y, Yang H, Yu Y, Wang Y, Zhang
J, Wang G, Zhang L, Sun B and Zhang Y: Bcl-2 expression is
associated with poor prognosis of solitary plasmacytoma of bone.
Ann Hematol. 93:471–477. 2014. View Article : Google Scholar
|
|
33
|
Ding JH, Yuan LY, Huang RB and Chen GA:
Aspirin inhibits proliferation and induces apoptosis of multiple
myeloma cells through regulation of Bcl-2 and Bax and suppression
of VEGF. Eur J Haematol. 93:329–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Korpis K, Weber F, Brune S, Wünsch B and
Bednarski PJ: Involvement of apoptosis and autophagy in the death
of RPMI 8226 multiple myeloma cells by two enantiomeric sigma
receptor ligands. Bioorg Med Chem. 22:221–233. 2014. View Article : Google Scholar
|
|
35
|
Fresquet V, Rieger M, Carolis C,
García-Barchino MJ and Martinez-Climent JA: Acquired mutations in
BCL2 family proteins conferring resistance to the BH3 mimetic
ABT-199 in lymphoma. Blood. 123:4111–4119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yadav P, Singh DD, Mukesh M, Kataria RS,
Yadav A, Mohanty AK and Mishra BP: Expression profiling of glucose
transporter 1 (GLUT1) and apoptotic genes (BAX and BCL2) in milk
enriched mammary epithelial cells (MEC) in riverine buffalo during
lactation. Anim Biotechnol. 25:151–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mantawy EM, El-Bakly WM, Esmat A, Badr AM
and El-Demerdash E: Chrysin alleviates acute doxorubicin
cardiotoxicity in rats via suppression of oxidative stress,
inflammation and apoptosis. Eur J Pharmacol. 728:107–118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pei XM, Yung BY, Yip SP, Ying M, Benzie IF
and Siu PM: Desacyl ghrelin prevents doxorubicin-induced myocardial
fibrosis and apoptosis via the GHSR-independent pathway. Am J
Physiol Endocrinol Metab. 306:E311–E323. 2014. View Article : Google Scholar
|
|
39
|
Poornima P, Kumar VB, Weng CF and Padma
VV: Doxorubicin induced apoptosis was potentiated by neferine in
human lung adenocarcima, A549 cells. Food Chem Toxicol. 68:87–98.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shokoohinia Y, Hosseinzadeh L, Moieni-Arya
M, Mostafaie A and Mohammadi-Motlagh HR: Osthole attenuates
doxorubicin-induced apoptosis in PC12 cells through inhibition of
mitochondrial dysfunction and ROS production. Biomed Res Int.
2014:1568482014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chiarello C, Bortoloso E, Carpi A, Furlan
S and Volpe P: Negative feedback regulation of Homer 1a on
norepinephrine-dependent cardiac hypertrophy. Exp Cell Res.
319:1804–1814. 2013. View Article : Google Scholar : PubMed/NCBI
|
